In this study we suggest, for the first time, the employment of MMP12 as biological drug in the anti-tumoral cell-based therapy in order to impair tumor angiogenesis and tumor invasion of melanoma and of all those tumor which heavily depend on uPAR to perform invasion. The gene discussed is PLAUR; the disease is neoplasm.